Event Date/Time: Jun 10, 2009 End Date/Time: Jun 10, 2009
Registration Date: Jun 10, 2009
Early Registration Date: Jun 09, 2009
Report as Spam

Description

Life Sciences companies today are facing greater challenges in maintaining regulatory compliance while pursuing increased profitability.

Key concerns that need to be addressed include:
• Increased regulatory scrutiny for compliance
• Optimizing costs for drug development and global safety reporting
• Increased distribution controls

Patni Life Sciences’ ADEPT™ (Adverse Event Processing Technology) is one of the leading offerings to provide a cost-effective mechanism to address these challenges.

Patni has:
• Global team of experts in strategic drug safety and pharmacovigilance
• Flexible staffing model allowing rapid response to changing demands
• State-of-the-art compliance knowledge and enabling toolkits
• Visualization solutions combined with detailed risk management planning to allow faster, low risk decision-making

Attend the Patni webinar to get insights on Pharmacovigilance visibility and reporting from Roy Devine, AVP (Drug Safety & Clinical) and Dr. Upender Kapoor, Global Director- Pharmacovigilance Operations. Learn how Patni is helping leading pharma companies remain complaint while reducing costs and improving effeciency.

URL for Registration:
https://patni.webex.com/patni/onstage/g.php?d=689096975&t=a

We sincerely hope you can join us.

Who Should Attend:
• VP-Safety & Compliance, Director, VP-R&D, Pharmacovigilance professionals
• Safety & Medical Directors
• Senior IT executives

Value of attending:
Learn more about trends and strategies in Pharmacovigilance and how Patni ADEPT KPO services can enable:
Support strategic assessments
• Risk Identification and Mitigation activities
• Process Evaluation and Optimization
• Trend Analysis for Proactive Management Decision Guidance
Execute operational business functions
• Collection, Processing, Analysis and Reporting of Adverse Events and Product Compliant Data
• Periodic Regulatory Safety Reporting
• Terminology and Labeling Management
• Routine Regulatory Compliance Auditing, e.g. vendor audits, clinical site audits, IT compliance audits
• Process Evaluation and Optimization
Focus on core research and development, e.g.
• Discovering and developing novel pharmaceuticals and devices
• Quality management right from development to distribution to the patient

Key benefits of ADEPTâ„¢

Enhanced Compliance:
• 21 CFR Part 11 compliant systems for Safety and Clinical Data Hosting and Enhanced E2B reporting capabilities
• Validated signaling and visualization systems for Pharmacovigilance and program management
• Client Compliance based SLA delivery model
Efficiency and quality:
• Increased visibility of metrics resulting in increased control
• Reduced cycle time and error rates for Pharmacovigilance activities
• Reporting mechanism to track process metrics and capture process performance
Cost Savings:
• Reduced Cost per Case and reduced regulatory Risk from enhanced reporting
• Reduced IT overhead and maintenance
• Global delivery model

Venue

Types